|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
The relative strength of AmTrust has been impressive for months, and volume trends continue to build.
Three companies get double nods from strategies of proven stock pickers.
The list expands to 28 with a new emphasis on financial services.
Small-caps that raise their dividends year after year signify company health and confident management.
Alexion Pharma is too far above established support to be considered a buy at this point, so wait for a pullback closer to this key level.